These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1928816)

  • 1. Effects of ticlopidine on erythrocyte aggregation in thrombotic disorders.
    Hayakawa M; Kuzuya F
    Angiology; 1991 Sep; 42(9):747-53. PubMed ID: 1928816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ticlopidine improves the enhanced erythrocyte aggregability in patients with cerebral infarction.
    Tanahashi N; Fukuuchi Y; Tomita M; Matsuoka S; Takeda H
    Stroke; 1993 Jul; 24(7):1083-6. PubMed ID: 8322384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advantages and shortcomings of platelet antiaggregants in the treatment of myocardial infarction].
    Nechaev DD; Bochko II; Martynov IV; Kuz'mina LF
    Ter Arkh; 1988; 60(8):59-63. PubMed ID: 2976211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ticlopidine-induced pancytopenia: therapy of agranulocytosis with granulocyte colony stimulating factor].
    Schneider AW; Fechler L; Gilfrich HJ
    Med Klin (Munich); 1996 Jun; 91(6):417-9. PubMed ID: 8767319
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased morning ADP-dependent platelet aggregation persists despite dual antiplatelet therapy in patients with first ST-segment elevation myocardial infarction: Preliminary report.
    Koziński M; Bielis L; Wiśniewska-Szmyt J; Sukiennik A; Grabczewska Z; Swiatkiewicz I; Ziołkowski M; Rość D; Kubica J
    Cardiol J; 2008; 15(6):530-6. PubMed ID: 19039757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of platelet antagonists on the ex vivo inhibitory effects of platelet aggregation].
    Sakata T; Kobayashi K; Katayama Y; Takada T; Matsuyama T
    Rinsho Byori; 1991 Mar; 39(3):315-20. PubMed ID: 2051607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study on the erythrocyte aggregating properties of polybrene and protamine sulphate.
    Inglis G; Sheridan R
    Transfusion; 1978; 18(1):84-8. PubMed ID: 625786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of ticlopidine on platelet function at rest and after exercise in patients with previous myocardial infarct. An acute crossover double-blind study].
    Tullio D; Valerio A; Ottaviano MA; Di Guglielmo L; Accettura P; Caraceni CE; Sclocco T
    Minerva Med; 1990; 81(1-2):87-92. PubMed ID: 2179769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte deformability and white blood cell count are associated with aspirin resistance in high-risk vascular patients.
    Mannini L; Marcucci R; Paniccia R; Antonucci E; Giglioli C; Valente S; Gori AM; Prisco D; Gensini GF; Abbate R
    Clin Hemorheol Microcirc; 2006; 35(1-2):175-81. PubMed ID: 16899924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparative evaluation of the effect of glurenorm and sulfonylurea preparations on the intravascular microcirculatory indices in type-II diabetes mellitus].
    Kakhnovskiĭ IM; Koroleva TV; Zakharchenko VN; Larionov SN
    Probl Endokrinol (Mosk); 1993; 39(2):7-9. PubMed ID: 8016059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of fructose-1,6-diphosphate and trental on the erythrocyte aggregating capacity in ischemic heart disease].
    Badalian GO; Episkoposian NG; Amatuni GV
    Ter Arkh; 1987; 59(7):92-5. PubMed ID: 3672368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of clopidogrel and ticlopidine on experimental diabetic ischemic retinopathy in rats.
    De La Cruz P; Arrebola M; González-Correa A; Martinez-Cerdán E; Moreno A; de la Cuesta FS
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):204-10. PubMed ID: 12595963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of exercise and ticlopidine on platelet function and prostanoids in patients with old myocardial infarction.
    Ding YA; Lee KW; Liang YB; Chang HC; Lin KC
    Taiwan Yi Xue Hui Za Zhi; 1989 Aug; 88(8):765-71. PubMed ID: 2592938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombocyte function inhibitors in stroke prevention. Ticlopidine as an alternative to acetylsalicylic acid].
    Busse O
    Fortschr Med; 1994 Sep; 112(27):365-6. PubMed ID: 7988969
    [No Abstract]   [Full Text] [Related]  

  • 15. [Aggregation of erythrocyte suspensions of diabetic patients in dextran 70 solutions].
    Khodabandehlou T; Le Devehat C
    J Mal Vasc; 1992; 17(2):107-11. PubMed ID: 1377219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registry.
    Olivier CB; Diehl P; Schnabel K; Weik P; Zhou Q; Bode C; Moser M
    Thromb Haemost; 2014 Feb; 111(2):266-72. PubMed ID: 24172891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ticlopidine for prevention of stroke.
    Med Lett Drugs Ther; 1992 Jul; 34(874):65-6. PubMed ID: 1614367
    [No Abstract]   [Full Text] [Related]  

  • 18. Ticlopidine hydrochloride.
    Blissitt PA
    J Neurosci Nurs; 1992 Oct; 24(5):296-300. PubMed ID: 1402156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of serum proteins on erythrocyte and thrombocyte aggregation].
    Mikheian EE; Akopov SE; Tunian IuS
    Patol Fiziol Eksp Ter; 1982; (1):23-5. PubMed ID: 7070851
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness of reloading to overcome clopidogrel nonresponsiveness in patients with acute myocardial infarction.
    Matetzky S; Fefer P; Shenkman B; Varon D; Savion N; Hod H
    Am J Cardiol; 2008 Sep; 102(5):524-9. PubMed ID: 18721506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.